| 10575 |
Apicidin
New |
|
183506-66-3 |
≥98%
|
|
|
2012-01-27
|
106.538339472068
|
apicidin
|
OSI 2040
|
funfal toxins malaria HDAC HAT histones deacetylase transcriptions epigenetics anticancer anti-cancer antiproliferation antiparasitic anti-proliferation anti-parasitic apicomplexan parasites HDAC3 HDAC-3 NcoR HDAC3/NcoR class I HDACs p21 WAF1/Cip1 WAF1 Cip1 gelsolin cells cycle morphology inhibits inhibitors inhibitions chromatin cancers deacetylase modification |
106.538339472068
|
| 89740 |
CAY10398
Exclusive |
|
- |
>98%
|
|
✓ |
|
47.516344996930
|
cay10398
|
|
reversible inhibitors histone deacetylase HD1 inhibits inhibitions CAY-10398 hdacs HDAC-1 HDACs HDAC 1 HDAC1 HDACIS |
47.516344996930
|
| 10005019 |
CAY10433
|
|
537034-17-6 |
>98%
|
|
|
2005-01-05
|
53.218406657117
|
cay10433
|
BML-210; N-phenyl-N'-(2-Aminophenyl)hexamethylenediamide
|
HDAC deacetylases histone inhibits inhibitors inhibition cancer cells differentiation gene expression regulation Trichostatin A nuclear extracts deacetylation transcription factors FOXO3 SIRT1 H2O2 hydrogen peroxides BML210 |
53.218406657117
|
| 13146 |
CAY10603
|
|
1045792-66-2 |
≥95%
|
|
|
2009-06-18
|
61.179438305709
|
cay10603
|
|
HDAC 6 inhibitors inhibits inhibition tubulin microtubule pancreatic cancers SAHA HDAC6 HDAC-6 HDACs HDACIs potent selective cells |
61.179438305709
|
| 13504 |
HDAC11 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-31
|
1.729558011049
|
hdac11-polyclonal-antibody
|
Histone Deacetylase 11
|
wb western immunoblotting HDACs HAT histones antibodies peptides blots blotting |
1.729558011049
|
| 13491 |
HDAC1 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-24
|
0.652209944751
|
hdac1-polyclonal-antibody
|
Histone Deactylase 1
|
HDAC-1 HDACs HDAC 1 antibodies WB western blots HATs immunoblotting blotting |
0.652209944751
|
| 13493 |
HDAC3 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-19
|
0.652209944751
|
hdac3-polyclonal-antibody
|
Histone Deacetylase 3
|
HDACs antibodies HATs histones acetyltransferase deacetylases western blotting WB IP immunoprecipation ChIP immunoblots immunoblotting blots |
0.652209944751
|
| 10009652 |
HDAC4 (human recombinant)
|
|
- |
>50% by SDS-PAGE
|
|
|
2010-03-01
|
19.093718657033
|
hdac4-human-recombinant
|
Histone Deacetylase 4
|
HDAC 4 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 |
19.093718657033
|
| 13500 |
HDAC7 (Phospho-Ser155) Polyclonal Antibody
|
|
- |
|
|
|
2009-07-29
|
1.823204419889
|
hdac7-phospho-ser155-polyclonal-antibody
|
Histone Deacetylase 7
|
antibodies MMP AR receptors matrix metalloproteinase androgens Nur77 histones deacetylases N-terminal immunoblotting blots western blotting WB |
1.823204419889
|
| 10009929 |
SAHA
|
|
149647-78-9 |
>98%
|
|
|
2007-08-07
|
164.175228067366
|
saha
|
Vorinostat; Suberoylanilide Hydroxamic Acid; Zolinza™
|
HDACs inhibitors cancers inhibits inhibition |
164.175228067366
|
| 10443 |
SB 939
New |
|
929016-96-6 |
≥98%
|
|
|
2012-02-06
|
103.307489257213
|
sb-939
|
3-[2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl]-N-hydroxy-(2E)-2-propenamide; Pracinostat
|
inhibits inhibitions inhibitor HDACs pan-HDAC panHDAC SB939 SB-939 histones deacetylase proliferation voronistat cancers tumors SAHA |
103.307489257213
|
| 89730 |
Trichostatin A
|
|
58880-19-6 |
>98%
|
|
|
|
156.614143646409
|
trichostatin-a
|
TSA
|
reversible inhibitors histone deacetylase nuclear receptors inhibitions inhibits hdacs TSAs cancers |
156.614143646409
|